• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR CP TOTAL HCG ASSAY; TOTAL HCG IMMUNOASSAY,

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR CP TOTAL HCG ASSAY; TOTAL HCG IMMUNOASSAY, Back to Search Results
Model Number N/A
Device Problem No Apparent Adverse Event (3189)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/05/2020
Event Type  malfunction  
Manufacturer Narrative
The customer contacted the siemens customer care center (ccc) to report discordant, falsely elevated advia centaur cp total human chorionic gonadotropin (hcg) result on a patient sample.The system event log has no errors at the time of the incident and quality control results were within acceptable range on (b)(6) 2020.A five patient repeatability check was performed.Patient repeatability check (n=5) results: sample 1 mean= 89.1 cv= 2.4, sample 2 mean= 1.496 cv= 9.65, sample 3 mean= 0.88 cv= 10.63, sample 4 mean= 0.872 cv= 9.22, sample 5 mean= 146.02 cv= 1.75.Siemens healthcare diagnostics is investigating.
 
Event Description
A falsely elevated advia centaur cp total human chorionic gonadotropin (hcg) result was obtained by the customer on a patient sample and considered discordant compared to a negative hcg result run at another hospital.The negative alternate hospital hcg result was reported to the physician(s) as the corrected result.There are no known reports that treatment was altered or prescribed or adverse health consequences due to the discordant advia centaur cp total human chorionic gonadotropin (hcg) result.
 
Manufacturer Narrative
Mdr 1219913-2020-00089 was filed on 12-mar-2020 for a falsely elevated advia centaur cp total human chorionic gonadotropin (hcg) patient result.Mdr 1219913-2020-00089 supplemental report 1 was filed on 07-apr-2020 for additional information.17-apr-2020 - additional information: siemens has been provided the advia centaur cp hcg reagent lot number.The physician(s) had questioned the elevated advia centaur cp total human chorionic gonadotropin (hcg) patient result and reported the patient was not pregnant.A siemens field application specialist checked and found the dark count, pipetting, sample probe, reagent probe and customer performed maintenance to be acceptable.D4.Lot # 309; expiration date 31-mar-2020.H4.Device manufacture date: 31-may-2019.23-apr-2020 - additional information: the information provided on 17-apr-2020 has been reviewed by siemens.The cause for the discordant high advia centaur cp hcg result is unknown.Contributing factors such as sample integrity and preanalytical variables cannot be ruled out.A potential product issue has not been identified.The customer is operational.The assay is performing within specification.No further evaluation of the device is required.
 
Manufacturer Narrative
Mdr 1219913-2020-00089 was filed on 12-mar-2020 for a falsely elevated advia centaur cp total human chorionic gonadotropin (hcg) patient result.On 16-mar-2020 - additional information: siemens has reviewed the event data and has concluded the incident investigation.The initial sample is no longer available for further investigation.No other results were questioned by the customer from the time of this event.The system event log was reviewed, and no errors were identified.Quality control results were within range on 05-feb-2020.A total hcg repeatability precision check was performed since this event and found acceptable.The cause for the discordant high result is unknown, however contributing factors such as sample integrity and preanalytical variables cannot be ruled out.A potential product issue has not been identified.The customer has not raised any additional concerns since this event.The assay is performing within specification.No further evaluation of the device is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR CP TOTAL HCG ASSAY
Type of Device
TOTAL HCG IMMUNOASSAY,
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown, ny
MDR Report Key9824956
MDR Text Key205962064
Report Number1219913-2020-00089
Device Sequence Number1
Product Code JHI
UDI-Device Identifier00630414505152
UDI-Public00630414505152
Combination Product (y/n)N
PMA/PMN Number
K925277
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 05/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/12/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2020
Device Model NumberN/A
Device Catalogue Number10308984
Device Lot Number309
Was Device Available for Evaluation? No
Date Manufacturer Received04/17/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-